Sanofi EBIT 2012-2026 | SNY

Sanofi EBIT for the quarter ending March 31, 2026 was $2.441B, a 0.07% decline year-over-year.

  • Sanofi 2025 EBIT was 9.831B, a 19.6% increase from 2024.
  • Sanofi 2024 EBIT was 8.22B, a 14.32% decline from 2023.
  • Sanofi 2023 EBIT was 9.594B, a 10.51% decline from 2022.

EBIT can be defined as earnings before interest and taxes.

Sanofi EBIT 2012-2026 | SNY

  • Sanofi 2025 EBIT was 9.831B, a 19.6% increase from 2024.
  • Sanofi 2024 EBIT was 8.22B, a 14.32% decline from 2023.
  • Sanofi 2023 EBIT was 9.594B, a 10.51% decline from 2022.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B